IDEXo — Idex Biometrics ASA Income Statement
0.000.00%
TechnologyHighly SpeculativeMicro Cap
- NOK57.98m
- NOK72.01m
- $4.14m
Annual income statement for Idex Biometrics ASA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | — | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.423 | 1.09 | 2.84 | 4.09 | 4.14 |
Cost of Revenue | |||||
Gross Profit | 0.361 | 0.82 | 1.59 | 0.847 | 0.23 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 32.5 | 27.5 | 34.2 | 35.5 | 31 |
Operating Profit | -32 | -26.4 | -31.4 | -31.4 | -26.8 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -32.3 | -26.9 | -32.5 | -32.7 | -26.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | -32.4 | -26.8 | -32.6 | -32.7 | -26.6 |
Net Income Before Extraordinary Items | |||||
Net Income | -32.4 | -26.8 | -32.6 | -32.7 | -26.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -32.4 | -26.8 | -32.6 | -32.7 | -26.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.269 | -0.169 | -0.172 | -0.158 | -0.095 |
Dividends per Share |